Agenus, Inc. (AGEN)
7.67
-0.42
(-5.19%)
USD |
NASDAQ |
Aug 24, 16:00
7.67
0.00 (0.00%)
After-Hours: 20:00
Agenus Shareholders Equity (Quarterly) : -199.08M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -199.08M |
| March 31, 2026 | -221.22M |
| December 31, 2025 | -271.11M |
| September 30, 2025 | -274.14M |
| June 30, 2025 | -354.60M |
| March 31, 2025 | -341.85M |
| December 31, 2024 | -326.38M |
| September 30, 2024 | -292.34M |
| June 30, 2024 | -241.31M |
| March 31, 2024 | -201.43M |
| December 31, 2023 | -160.33M |
| September 30, 2023 | -129.11M |
| June 30, 2023 | -93.20M |
| March 31, 2023 | -58.54M |
| December 31, 2022 | -61.28M |
| September 30, 2022 | -20.38M |
| June 30, 2022 | 3.416M |
| March 31, 2022 | 15.72M |
| December 31, 2021 | 34.44M |
| September 30, 2021 | 41.85M |
| June 30, 2021 | -228.84M |
| March 31, 2021 | -167.06M |
| December 31, 2020 | -176.76M |
| September 30, 2020 | -171.57M |
| June 30, 2020 | -191.70M |
| Date | Value |
|---|---|
| March 31, 2020 | -169.00M |
| December 31, 2019 | -198.44M |
| September 30, 2019 | -172.77M |
| June 30, 2019 | -130.31M |
| March 31, 2019 | -82.74M |
| December 31, 2018 | -132.59M |
| September 30, 2018 | -130.41M |
| June 30, 2018 | -112.71M |
| March 31, 2018 | -113.39M |
| December 31, 2017 | -75.82M |
| September 30, 2017 | -51.59M |
| June 30, 2017 | -17.48M |
| March 31, 2017 | 8.905M |
| December 31, 2016 | -39.13M |
| September 30, 2016 | -21.04M |
| June 30, 2016 | 16.88M |
| March 31, 2016 | 44.45M |
| December 31, 2015 | 70.73M |
| September 30, 2015 | 76.98M |
| June 30, 2015 | 87.19M |
| March 31, 2015 | 46.26M |
| December 31, 2014 | 23.02M |
| September 30, 2014 | 48.87M |
| June 30, 2014 | 57.63M |
| March 31, 2014 | 63.29M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Iovance Biotherapeutics, Inc. | 736.04M |
| Novavax, Inc. | -190.71M |
| Fate Therapeutics, Inc. | 153.44M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 172.69M |
| Total Liabilities (Quarterly) | 378.54M |
| Debt to Equity Ratio | -1.458 |
| Current Ratio | 0.34 |
| Net Debt Paydown Yield | 19.44% |